Gregory T. Went, Chief Executive Officer, 10% Owner at Adamas Pharmaceuticals Inc (ADMS), sold 300 shares at $18.00 ($5K) on 2015-03-20, disclosed to the SEC on 2015-03-24.
Scheduled sale ($5k) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.00 | 100 | $2K | 33.3% |
| 2 | $18.00 | 200 | $4K | 66.7% |
| Total | $18.00 avg | 300 | $5K | 100% |
| Filing → |
| ADMS | SELL | 2018-03-22 | $234K | — | Filing → |
| ADMS | SELL | 2017-03-22 | $48K | — | Filing → |
| ADMS | SELL | 2015-05-14 | $49K | — | Filing → |